Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II

Tsung-Mu Yang; Nirmish Singla; Chung-Hsin Chen; Jer-Tsong Hsieh; Hsin-Chih Yeh

doi:10.3389/fonc.2023.1276718

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II

Front Oncol. 2023 Sep 5:13:1276718. doi: 10.3389/fonc.2023.1276718. eCollection 2023.

Authors

Tsung-Mu Yang¹, Nirmish Singla², Chung-Hsin Chen³, Jer-Tsong Hsieh⁴, Hsin-Chih Yeh^{5

6

7

8}

Affiliations

¹ Department of General Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
² Brady Urological Institute, School of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
³ Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.
⁴ Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
⁵ Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
⁶ Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
⁷ Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
⁸ Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

No abstract available

Keywords: CCAAT/enhancer-binding protein delta; immunochemotherapy; nomogram; precision oncology; surgical wait time; upper tract urothelial carcinoma.

Publication types

Editorial